UPC_CFI_146/2024

NOVEL ANTITUMORAL USE OF CABAZITAXEL

VerletzungHauptverletzungsklageMunich LDInfringementCase Closed

Dieser Fall zitiert

In den Entscheidungen dieses Falls zitierte Quellen.

Quelle	Rechtsfrage	Bindungskraft	Auszug
RoP_rule 353	rectification of decisions and orders	Bindend	Application pursuant to Rule 353 – Rectification of decisions and orders
RoP_rule 334	outstanding applications no longer need adjudication when infringement action dismissed	Bindend	As the infringement actions are dismissed, any other outstanding applications and requests relating to them no longer need to be adjudicated (R. 334 RoP).
RoP_rule 30	auxiliary requests for patent amendment	Bindend	Sanofi did not file an application pursuant to Rule 30 of the Rules of procedure. Therefore, no auxiliary requests must be considered.

Quelle	Rechtsfrage	Bindungskraft	Auszug
Art. 73 UPCA	appeal rights; time limit	Bindend	An appeal against the present Decision may be lodged at the Court of Appeal, by any party which has been unsuccessful, in whole or in part, in its submissions, within two months of the date of its notification (Art. 73(1) UPCA

Zitiert in

Spätere UPC-Entscheidungen, die diesen Fall zitieren.

Bisher in keiner anderen Entscheidung unseres Korpus zitiert.